Brussels, Belgium, August 16, 2016

Merodis, an independent corporate finance advisory boutique, is pleased to announce that it successfully advised Oystershell Laboratories related to the sale of its animal health business activities to Artuvet Animal Health.

Oystershell Laboratories is a fast-growing pharmaceutical company specialized in the innovation of consumer healthcare products (OTC), by combining scientific progress with greater consumer satisfaction. Oystershell Laboratories develops non-prescription pharmaceuticals, medical devices, insect protection, cosmeceutical and nutritional products to keep you and your family healthy.

Artuvet Animal Health is an innovative pharmaceutical company originating out of a recent carve-out of the European veterinary business of the Danish pharmaceutical company ALK-Abelló.

For more information, please contact:

Dirk Marckx
dma@merodis.com, +32 495 38 17 81
Rodolphe Blondiau
rbl@merodis.com, +32 488 81 45 07